Design and tests of an HIV vaccine.
Citations
47 citations
Cites background from "Design and tests of an HIV vaccine...."
..., 2002, 2003) suggesting that activation of the humoral and cellular immune response is necessary for a potent HIV vaccine (McMichael and Hanke, 2003; McMichael et al., 2002)....
[...]
42 citations
39 citations
Cites methods from "Design and tests of an HIV vaccine...."
...One of the prospective measures is to evoke host immunity by delivering recombinant vector-based vaccines expressing recombinant antigens, e.g., modified vaccinia virus Ankara (4, 21), adenovirus type 5 (29), fowlpox virus (16), canarypox virus (8), and NYVAC (5)....
[...]
..., modified vaccinia virus Ankara (4, 21), adenovirus type 5 (29), fowlpox virus (16), canarypox virus (8), and NYVAC (5)....
[...]
31 citations
27 citations
Cites result from "Design and tests of an HIV vaccine...."
...In agreement with the findings of others (31, 34), our data indicated that mucosal inoculation induced the strongest immune response at mucosal sites, rather than systemic sites....
[...]
References
2,276 citations
1,480 citations
1,455 citations
1,290 citations
1,240 citations